Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by City Therapeutics, Inc.

News headline image
City Therapeutics Announces $99.5 Million Series B Financing to Advance Next-Generation RNAi Therapeutics
From City Therapeutics, Inc.
Via Business Wire
News headline image
City Therapeutics Presents Preclinical Data on Next-Generation Investigational RNAi Therapy CITY-RBP4 for Treatment of Stargardt Disease at ARVO 2026 Annual Meeting
From City Therapeutics, Inc.
Via Business Wire
News headline image
City Therapeutics Announces Submission of Clinical Trial Application for CITY-FXI, an Investigational RNAi Therapeutic for the Treatment of Thromboembolic Diseases
From City Therapeutics, Inc.
Via Business Wire
News headline image
City Therapeutics Expands Executive Team and Board of Directors
From City Therapeutics, Inc.
Via Business Wire
News headline image
City Therapeutics Announces Strategic Collaboration with Bausch + Lomb to Develop a Novel RNAi-Based Treatment for Geographic Atrophy
From City Therapeutics, Inc.
Via Business Wire
News headline image
City Therapeutics Appoints Andy Orth as Chief Executive Officer
From City Therapeutics, Inc.
Via Business Wire
News headline image
City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine
From City Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.